Role of Hysteropexy in the Management of Pelvic Organ Prolapse

Curr Urol Rep. 2022 Sep;23(9):175-183. doi: 10.1007/s11934-022-01101-0. Epub 2022 Jul 5.

Abstract

Purpose of review: To discuss considerations for hysteropexy for apical pelvic organ prolapse (POP) and summarize available literature comparing various hysteropexy techniques to analogous procedures involving hysterectomy.

Recent findings: Hysteropexy for apical POP has increased in popularity in recent years, although anatomic factors and gynecologic cancer risk must be taken into account. Native tissue hysteropexy options include the LeFort colpocleisis, sacrospinous hysteropexy, and uterosacral hysteropexy. Although vaginal mesh was banned by the Food and Drug Administration in 2019, abdominal mesh sacrohysteropexy done either open or laparoscopically remains an option in the USA. Overall, short-term prolapse outcomes appear to be comparable between uterus-sparing approaches and hysterectomy, with less blood loss and shorter operating room time observed with the uterine-sparing approaches, although long-term outcome data remains variable and limited. Uterine-sparing apical POP repair may be offered to appropriate patients without certain risk factors, although longer-term data will be required to evaluate durability.

Keywords: Hysterectomy; Hysteropexy; Pelvic organ prolapse; Uterus sparing.

Publication types

  • Review

MeSH terms

  • Female
  • Gynecologic Surgical Procedures / methods
  • Humans
  • Pelvic Organ Prolapse* / surgery
  • Treatment Outcome
  • United States
  • Uterine Prolapse* / surgery
  • Uterus / surgery